医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

EULAR/ACR risk stratification criteria for development of rheumatoid arthritis in the risk stage of arthralgia.

广告
第一作者: Hanna W,van Steenbergen
第一单位: Department of Rheumatology, Leiden University Medical Centre, Leiden, the Netherlands.
作者单位: Department of Rheumatology, Leiden University Medical Centre, Leiden, the Netherlands. [1] Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, the Netherlands. [2] Division of Rheumatology, Fondazione Policlinico Universitário A. Gemelli Istituto di Ricovero e Cura a Carattere Scientifico-Università Cattolica del Sacro Cuore, Rome, Italy. [3] At-risk participant. [4] Center for Rheumatic Diseases, University of Medicine and Pharmacy, Bucharest, Romania. [5] University of Texas Southwestern Medical School, Dallas, TX, USA. [6] Montpellier University, Montpellier, France. [7] Centre for Rheumatic Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK. [8] University of Colorado Anschutz Medical Campus, Aurora, CO, USA. [9] Veterans Affairs Nebraska-Western Iowa Health Care System & University of Nebraska Medical Center, Omaha, NE, USA. [10] Department of Inflammation and Ageing, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, UK. [11] Department of Rheumatology, Erasmus Medical Centre, Rotterdam, the Netherlands. [12] Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany; Department of Internal Medicine 3, Rheumatology and Immunology University Hospital Erlangen and Friedrich Alexander University (FAU), Erlangen, Germany. [13] Arthritis Research Canada, Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada. [14] Patient Research Partner European Alliance of Associations for Rheumatology People with Arthritis and Rheumatism in Europe and National Association ReumaZorg Nederland, the Netherlands. [15] Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and National Institute for Health and Care Research Leeds Biomedical Research Centre, Leeds Teaching Hospitals National Health Services Trust, Leeds, UK. [16] Department of Rheumatology, Leiden University Medical Centre, Leiden, the Netherlands; Department of Rheumatology, Erasmus Medical Centre, Rotterdam, the Netherlands. [17] Department of Rheumatology and Clinical Immunology, Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary; Heart and Vascular Center, Semmelweis University, Budapest, Hungary; Department of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary; National Institute of Locomotor Diseases and Disabilities, Budapest, Hungary. [18] Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada. [19] Department of Rheumatology, University of Colorado School of Medicine, Aurora, CO, USA. [20] Department of Inflammation and Ageing, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, UK; National Institute for Health and Care Research Birmingham Biomedical Research Center and Clinical Research Facility, University of Birmingham, Queen Elizabeth Hospital, Birmingham, UK. [21] Amsterdam Rheumatology Center, Reade, Amsterdam, the Netherlands. [22] Department of Rheumatology, Leiden University Medical Centre, Leiden, the Netherlands; Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal. [23] Department of Rheumatology, Centro Hospitalar e Universitário de Coimbra, Institute for Clinical and Biomedical Research, Faculty of Medicine, University of Coimbra, Portugal. [24] Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. [25] Department of Internal Medicine 3, Division of Rheumatology, Medical University of Vienna, Vienna, Austria; Department of Medicine (Solna), Division of Rheumatology, Karolinska Institute, Stockholm, Sweden. [26] Patient research partner, Department of Information Services and Technology, National Jewish Health, Denver, CO, USA. [27] Rheumatology & Clinical Immunology, Amsterdam University Medical Center, Amsterdam, the Netherlands; Department of Rheumatology, Zuyderland Medical Center, Heerlen, the Netherlands. [28] Department of Inflammation and Ageing, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, UK; Department of Rheumatology, Bronglais Hospital, Hywel Dda University Health Board, Aberystwyth, UK. [29] Department of Rheumatology, Leiden University Medical Centre, Leiden, the Netherlands; Department of Rheumatology, Erasmus Medical Centre, Rotterdam, the Netherlands. Electronic address: a.h.m.van_der_helm@lumc.nl. [30]
DOI 10.1016/j.ard.2025.01.021
PMID 40447498
发布时间 2025-09-06
提交
  • 浏览0
Annals of the rheumatic diseases

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷